Clinical trial Recruiting at 1 site Interventional Ages 18 to 35

Modulating brain activity to improve working memory

Official title: State-dependent Modulation of Interactions of Theta and Gamma Rhythms in Working Memory

Run by Massachusetts General Hospital · NCT05923606 · Data updated 2026-11-12

This study is testing if a type of brain stimulation can help healthy adults improve their working memory while they complete a memory task.

Quick facts

Study typeInterventional
Ages18 Years to 35 Years
SexAll
Enrollment32 (estimated)
SponsorMassachusetts General Hospital
Academic / other
Locations1 site (Charlestown, Massachusetts)
StatusRecruiting
StartedJuly 10, 2024
Main results expectedDecember 31, 2026
Study endsMarch 31, 2027
Registry record updatedOctober 7, 2026
Trial IDNCT05923606 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy adults who are fluent in English and can provide informed consent.

Probably not a fit

Patients with a history of neurological or psychiatric disorders or those currently using certain medications may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of transcranial alternating current stimulation (tACS) on brain oscillations related to working memory in healthy adults. Participants will perform a spatial working memory task while their brain activity is recorded using electroencephalography (EEG). They will undergo four different tACS sessions, including active and placebo conditions, to assess how varying stimulation protocols influence their cognitive performance. The study aims to enhance our understanding of the neural mechanisms underlying working memory.

Why it matters

Potential benefit: If successful, this study could lead to new noninvasive methods for enhancing working memory in individuals.

How similar studies have gone: Other studies using tACS have shown promising results in modulating cognitive functions, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Able to provide informed consent
* Fluent in English.

Exclusion Criteria:

* History of a neurological/psychiatric disorder
* Current use of psychotropic medications
* Current use of substances and drugs that were shown to affect tES (transcranial electrical stimulation) efficacy (dopamine altering drugs, nicotine, NMDA (N-methyl-D-aspartate) antagonists/agonists, sodium/calcium channel blockers, norepinephrine reuptake inhibitors, GABAergic modulators and selective serotonin reuptake inhibitors)
* Contraindications for tACS (e.g., history of seizures, metallic implants in the head or neck, implanted brain stimulators, vagus nerve stimulators, pacemakers, pregnancy)

Where it's running

  • Martinos Center for Biomedical Imaging
    Charlestown, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.